v3.23.3
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   28,960,000      
Beginning balance at Dec. 31, 2021 $ 337,118 $ 3 $ 553,773 $ (216,119) $ (539)
Equity          
Stock option exercises (in shares)   2,000      
Stock option exercises 15   15    
Stock-based compensation expense 5,102   5,102    
Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes (in shares)   7,000      
Net loss (29,952)     (29,952)  
Other comprehensive income (loss) (1,098)       (1,098)
Ending balance (in shares) at Mar. 31, 2022   28,969,000      
Ending balance at Mar. 31, 2022 311,185 $ 3 558,890 (246,071) (1,637)
Beginning balance (in shares) at Dec. 31, 2021   28,960,000      
Beginning balance at Dec. 31, 2021 337,118 $ 3 553,773 (216,119) (539)
Equity          
Net loss (93,919)        
Other comprehensive income (loss) (1,283)        
Ending balance (in shares) at Sep. 30, 2022   29,690,000      
Ending balance at Sep. 30, 2022 281,741 $ 3 593,598 (310,038) (1,822)
Beginning balance (in shares) at Mar. 31, 2022   28,969,000      
Beginning balance at Mar. 31, 2022 311,185 $ 3 558,890 (246,071) (1,637)
Equity          
Stock option exercises (in shares)   25,000      
Stock option exercises 136   136    
Stock-based compensation expense 5,777   5,777    
Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes (in shares)   (3,000)      
Issue stock for employee stock purchase plan (in shares)   15,000      
Issue stock for employee stock purchase plan 75   75    
Net loss (32,158)     (32,158)  
Other comprehensive income (loss) (281)       (281)
Ending balance (in shares) at Jun. 30, 2022   29,006,000      
Ending balance at Jun. 30, 2022 284,734 $ 3 564,878 (278,229) (1,918)
Equity          
Stock option exercises (in shares)   13,000      
Stock option exercises 111   111    
Stock-based compensation expense 6,059   6,059    
Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes (in shares)   7,000      
Issue common stock, net of issuance costs (in shares)   664,000      
Issue common stock, net of issuance costs 22,550   22,550    
Net loss (31,809)     (31,809)  
Other comprehensive income (loss) 96       96
Ending balance (in shares) at Sep. 30, 2022   29,690,000      
Ending balance at Sep. 30, 2022 $ 281,741 $ 3 593,598 (310,038) (1,822)
Beginning balance (in shares) at Dec. 31, 2022 29,718,000 29,718,000      
Beginning balance at Dec. 31, 2022 $ 249,398 $ 3 599,234 (348,715) (1,124)
Equity          
Stock option exercises (in shares)   4,000      
Stock option exercises 23   23    
Stock-based compensation expense 3,882   3,882    
Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes (in shares)   7,000      
Issue common stock, net of issuance costs (in shares)   950,000      
Issue common stock, net of issuance costs 14,848   14,848    
Net loss (37,124)     (37,124)  
Other comprehensive income (loss) 459       459
Ending balance (in shares) at Mar. 31, 2023   30,679,000      
Ending balance at Mar. 31, 2023 $ 231,486 $ 3 617,987 (385,839) (665)
Beginning balance (in shares) at Dec. 31, 2022 29,718,000 29,718,000      
Beginning balance at Dec. 31, 2022 $ 249,398 $ 3 599,234 (348,715) (1,124)
Equity          
Stock option exercises (in shares) 4,000        
Net loss $ (188,602)        
Other comprehensive income (loss) $ 1,031        
Ending balance (in shares) at Sep. 30, 2023 35,349,000 35,349,000      
Ending balance at Sep. 30, 2023 $ 118,999 $ 3 656,406 (537,317) (93)
Beginning balance (in shares) at Mar. 31, 2023   30,679,000      
Beginning balance at Mar. 31, 2023 231,486 $ 3 617,987 (385,839) (665)
Equity          
Stock option exercises 1   1    
Stock-based compensation expense 3,932   3,932    
Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes (in shares)   (6,000)      
Issue common stock, net of issuance costs (in shares)   2,552,000      
Issue common stock, net of issuance costs 17,802   17,802    
Issue stock for employee stock purchase plan (in shares)   15,000      
Issue stock for employee stock purchase plan 92   92    
Net loss (38,912)     (38,912)  
Other comprehensive income (loss) 355       355
Ending balance (in shares) at Jun. 30, 2023   33,240,000      
Ending balance at Jun. 30, 2023 214,756 $ 3 639,814 (424,751) (310)
Equity          
Stock-based compensation expense 3,992   3,992    
Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes (61)   (61)    
Issue common stock, net of issuance costs (in shares)   2,109,000      
Issue common stock, net of issuance costs 12,661   12,661    
Net loss (112,566)     (112,566)  
Other comprehensive income (loss) $ 217       217
Ending balance (in shares) at Sep. 30, 2023 35,349,000 35,349,000      
Ending balance at Sep. 30, 2023 $ 118,999 $ 3 $ 656,406 $ (537,317) $ (93)